Recent

% | $
Quotes you view appear here for quick access.

ONYX Pharmaceuticals, AŞ Message Board

  • woodyvhi woodyvhi Aug 2, 2000 1:15 AM Flag

    Not even thru PhaseII yet...<gg>

    Not even thru PhaseII yet...<gg>
    "Early
    results promising" ...but this run is way overdone.


    These results based on early phaseII trials on just 30
    patients, with head and neck cancers.

    ...there's an
    aweful long long way to go before you get thru phase
    III
    (one year? ...2 years?) !!


    There is a great
    risk here ,expecting this to run farther than it
    already has....once the daytrader's leave , IMO.



    ""And promising as ONYX-015 is, it has a weakness. The
    substance must be injected directly into the tumor to work.
    This makes it ineffective against tumors that are hard
    to reach or are too small to detect.
    "

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • entire float traded - 8mm shares at 11:43

    • Tuesday, June 6, 2000 - Onyx Announces Initiation of Phase III Clinical Trial of CI-1042 (ONYX-015) in Patients with Head and Neck Cancer

    • Not even thru PhaseII yet...<gg>NO DRUG,
      ONLY RESERCH. NO EARNING. THIS IS BOT REAL. BACK TO 10
      RANGE SOON.
      "Early results promising" ...but this
      run is way overdone.

      These results based on
      early phaseII trials on just 30 patients, with head and
      neck cancers.

      ...there's an aweful long long
      way to go before you get thru phase III
      (one year?
      ...2 years?) !!


      There is a great risk here
      ,expecting this to run farther than it already has....once
      the daytrader's leave , IMO.


      ""And
      promising as ONYX-015 is, it has a weakness. The substance
      must be injected directly into the tumor to work. This
      makes it ineffective against tumors that are hard to
      reach or are too small to detect.
      "

    • Look at the company notthe scared shorts

    • Not even thru PhaseII yet...<gg>NO
      Not
      even thru PhaseII yet...<gg>NO DRUG, ONLY
      RESERCH. NO EARNING. THIS IS BOT REAL. BACK TO 10 VERY
      SOON.
      "Early results promising" ...but this run is way
      overdone.

      These results based on early phaseII
      trials on just 30 patients, with head and neck
      cancers.

      ...there's an aweful long long way to go before you get thru
      phase III
      (one year? ...2 years?)
      !!


      There is a great risk here ,expecting this to run
      farther than it already has....once the daytrader's leave
      , IMO.


      ""And promising as ONYX-015 is,
      it has a weakness. The substance must be injected
      directly into the tumor to work. This makes it ineffective
      against tumors that are hard to reach or are too small to
      detect.
      "

    • Not even thru PhaseII yet...<gg>NO DRUG,
      ONLY RESERCH. NO EARNING. THIS IS BOT REAL. BACK TO 10
      VERY SOON.
      "Early results promising" ...but this
      run is way overdone.

      These results based on
      early phaseII trials on just 30 patients, with head and
      neck cancers.

      ...there's an aweful long long
      way to go before you get thru phase III
      (one year?
      ...2 years?) !!


      There is a great risk here
      ,expecting this to run farther than it already has....once
      the daytrader's leave , IMO.


      ""And
      promising as ONYX-015 is, it has a weakness. The substance
      must be injected directly into the tumor to work. This
      makes it ineffective against tumors that are hard to
      reach or are too small to detect.
      "


      --------------------------------------------------------------------------------

    • Not even thru PhaseII yet...<gg>NO DRUG,
      ONLY RESERCH. NO EARNING. THIS IS BOT REAL.
      "Early
      results promising" ...but this run is way overdone.


      These results based on early phaseII trials on just 30
      patients, with head and neck cancers.

      ...there's an
      aweful long long way to go before you get thru phase
      III
      (one year? ...2 years?) !!


      There is a great
      risk here ,expecting this to run farther than it
      already has....once the daytrader's leave , IMO.



      ""And promising as ONYX-015 is, it has a weakness. The
      substance must be injected directly into the tumor to work.
      This makes it ineffective against tumors that are hard
      to reach or are too small to detect.
      "


      --------------------------------------------------------------------------------

    • Not even thru PhaseII yet...<gg>NO DRUG,
      ONLY RESERCH. NO EARNING. THIS IS BOT REAL.
      "Early
      results promising" ...but this run is way overdone.


      These results based on early phaseII trials on just 30
      patients, with head and neck cancers.

      ...there's an
      aweful long long way to go before you get thru phase
      III
      (one year? ...2 years?) !!


      There is a great
      risk here ,expecting this to run farther than it
      already has....once the daytrader's leave , IMO.



      ""And promising as ONYX-015 is, it has a weakness. The
      substance must be injected directly into the tumor to work.
      This makes it ineffective against tumors that are hard
      to reach or are too small to detect.
      "

    • Not even thru PhaseII yet...<gg>
      "Early
      results promising" ...but this run is way overdone.


      These results based on early phaseII trials on just 30
      patients, with head and neck cancers.

      ...there's an
      aweful long long way to go before you get thru phase
      III
      (one year? ...2 years?) !!


      There is a great
      risk here ,expecting this to run farther than it
      already has....once the daytrader's leave , IMO.



      ""And promising as ONYX-015 is, it has a weakness. The
      substance must be injected directly into the tumor to work.
      This makes it ineffective against tumors that are hard
      to reach or are too small to detect.
      "


      --------------------------------------------------------------------------------

    • Not even thru PhaseII yet...<gg>
      "Early
      results promising" ...but this run is way overdone.


      These results based on early phaseII trials on just 30
      patients, with head and neck cancers.

      ...there's an
      aweful long long way to go before you get thru phase
      III
      (one year? ...2 years?) !!


      There is a great
      risk here ,expecting this to run farther than it
      already has....once the daytrader's leave , IMO.



      ""And promising as ONYX-015 is, it has a weakness. The
      substance must be injected directly into the tumor to work.
      This makes it ineffective against tumors that are hard
      to reach or are too small to detect.
      "


      --------------------------------------------------------------------------------

    • View More Messages